The role of oval cells and gap junctional intercellular communication in hepatocarcinogenesis

Anticancer Research

Volumn 19, Issue 6 A, 1999, Pages 4831-4838

  Ruch, Randall J ^a   Trosko, James E ^b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Gap junctions; Hepatocarcinogenesis; Intercellular communication; Oval cells

Indexed keywords

CARCINOGEN; CONNEXIN 32; CONNEXIN 43; PEPTIDE;

BILE DUCT CARCINOMA; CELL COMMUNICATION; EPITHELIUM CELL; GAP JUNCTION; HUMAN; LIVER CARCINOGENESIS; LIVER CELL; LIVER REGENERATION; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL; TISSUE DIFFERENTIATION;

ANIMALS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL DIVISION; GAP JUNCTIONS; LIVER NEOPLASMS, EXPERIMENTAL;

EID: 0033368072     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Pilot HC and Dragan YP: The multistage nature of chemically induced hepatocarcinogenesis in the rat. Drug Metab Rev 26: 209-220, 1994.
2. Farber E: The sequential analysis of cancer induction with chemicals. Acta Pathol Jpn 31: 1-11, 1981.
3. Sell S: Cellular origin of cancer: Dedifferentiation or stem cell maturation arrest? Environ Hlth Persp 101 (suppl. 5): 15-26, 1993.
4. Sirica AE: Ductular hepatocytes. Histol Histopathol 10: 433-456, 1995.
5. Fausto N, Lemire JM and Shiojiri N: Cell lineages in hepatic development and the identification of progenitor cells in normal and injured liver. Proc Soc Exp Biol Med 204: 237-241, 1993.
6. Grisham JW: Migration of hepatocytes along hepatic plates and stem cell-fed hepatocyte lineages. Am J Pathol 144: 849-854, 1994.
7. Petersen BE, Zajac VF and Michalopoulos GK: Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology 27: 1030-1038, 1998.
8. Alison MR, Golding M and Sarraf CE: Liver stem cells: when the going gets tough they get going. Int J Exp Path 78: 365-381, 1997.
9. Thorgiersson SS, Evarts RB, Bisgaard C, Fujio K, and Hu Z: Hepatic stem cell compartment: activation and lineage commitment. Proc Soc Exp Biol Med 204: 253-260, 1993.
10. Loewenstein WR: Junctional intercellular communication and the control of growth. Biochim Biophys Acta. 560: 1-65, 1979.
11. Trosko JE and Ruch RJ: Cell-cell communication in carcinogenesis. Front Biosci 3: D208-D236, 1998.
12. Meyer DJ, Yancey SB and Revel JP: Intercellular communication in normal and regenerating rat liver: a quantitative analysis. J Cell Biol 91: 505-523, 1981.
13. Yamasaki H, Kjutovskikh V, Mesnil M, Columbano A, Tsuda H and Ito N: Gap functional intercellular communication and cell proliferation during rat liver carcinogenesis. Environ Health Perspect 101 (Suppl5): 191-147, 1993.
14. Klaunig JE and Ruch RJ: Role of inhibition of intercellular communication in carcinogenesis. Lab Invest 62: 135-146, 1990.
15. Mesnil M, Fraslin JM, Piccoli C, Yamasaki H, and Guguen-Guillouzo C: Cell contact but not junctional communication (dye coupling) with biliary epithelial cells is required for hepatocytes to maintain differentiated functions. Exp Cell Res 173: 524-533, 1987.
16. Ren P and Ruch RJ: Long-term maintenance of gap junctional intercellular communication and connexin32 expression by dexamethasone in rat hepatocyte-WB-F344 rat liver epithelial cell cocultures. In Vitro Toxicol 9: 419-429, 1996.
17. Barrett JC: Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ Hlth Persp 100: 9-20, 1993.
18. Pilot HC, Dragan Y, Xu Y, Peterson J, Hully J and Campbell H: Pathways of carcinogenesis - genetic and epigenetic. Princess Takamatsu Symp 22: 21-33, 1991.
19. Counts JL and Goodman JI: Hypomethylation of DNA: an epigenetic mechanism involved in tumor promotion. Mol Carcinog 11: 185-188, 1994.
20. MacLeod MC: A possible role in chemical carcinogenesis for epigenetic, heritable changes in gene expression. Mol Carcinog 15: 241-250, 1996.
21. Rubin H: Epigenetic nature of neoplastic transformation. In: Developmental Biology and Cancer (Hodges G and Rowlatt M, eds). Boca raton, FL, CRC Press, 1994, pp 61-84.
22. Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87: 159-170, 1996.
23. Beer DG, Neveu MJ, Paul DL, Rapp UR and Pilot HC: Expression of the c-raf protooncogene, gamma-glutamyltranspeptidase, and gap junction protein in rat liver neoplasms. Cancer Res 48: 1610-1617, 1988.
24. Lennartsson P, Hogberg J and Stenius U: Wild-type p53 expression in liver tissue and in enzyme-altered foci: an in vivo investigation on diethylnitrosamine-treated rats. Carcinogenesis 19: 1231-1237, 1998.
25. Weghorst CM and Klaunig JE: Phenobarbital promotion in diethylnitrosamine-initiated infant B6C3F1 mice: influence of gender. Carcinogenesis 10: 609-612, 1989.
26. Schulte-Hermann R, Timmermann-Trosiener I, Barthel G and Bursch W: DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res 50: 5127-5135, 1990.
27. Sargent L, Dragan Y, Xu YH, Sattler G, Wiley J and Pilot HC: Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat. Cancer Res 56: 2985-2991, 1996.
28. Opie EI: The pathogenesis of tumors of the liver produced by butter yellow. J Exp Med 80: 231-246, 1944.
29. Farber E: Similarities in the sequences of early histological changes induced in the liver of the rat by ethionine, 2-acetylaminofluorene, and 3£-methyl-4-dimethylaminobenzene. Cancer Res 16: 142-148, 1956.
30. Grisham JW: Cell types in long-lerm propagable cullures of rat liver. Ann N Y Acad Sci 349: 128-137, 1980.
31. Tsao MS, Smith JD, Nelson KG and Smith JD: A diploid epithelial cell line from normal adult rat liver with phenotypic properties of "oval" cells. Exp Cell Res 154: 38-52, 1984.
32. Yaswen P, Hayner NT and Fausto N: Isolation of oval cells by centrifugal elutriation and comparison with other cell types purified from normal and preneoplastic livers. Cancer Res 44: 332-338, 1984.
33. Garfied MA, Huher BE, Nagy P, Cordingley NG and Thorgiersson SS: Neoplastic transformation and lineage switching of rat liver epithelial cells by retrovirus-associated oncogenes. Mol Carcinog 1: 189-195, 1988.
34. Coletnan WB, Wennenberg AE, Smith GJ and Grisham JW: Regulation of the differentiation of diploid and some aneuploid rat liver epithelial (stem-like) cells by the hepatic microenvironment. Am J Pathol 142: 1373-1382, 1993.
35. Tsao MS and Grisham JW: Hepatocarcinomas, cholangiocarcinomas, and hepatoblaslomas produced by chemically transformed cultured rat liver epithelial cells. A light- and electron-microscopic analysis. Am J Pathol 127: 168-181, 1987.
36. Schrenk D, Eisenmann-Tappe I, Gebhardt R, Mayer D, el Mouelhi M, Rohrdanz E, Munzel P and Bock KW: Drug metabolizing enzyme activities in rat liver epithelial cell lines, hepatocytes and bile duct cells. Biochem Pharmacol 41: 1751-1757, 1941.
37. Utesch D, Traiser M, Gath I, Dorresteijn AWC, Maier P and Oesch F: Effects of sodium butyrate on DNA content, glutathione S-transferase activities, cell morphology and growth characteristics of rat liver parenchymal epithelial cells in vitro. Carcinogenesis 14: 457-462, 1993.
38. Steinberg P, Steinbrecher R, Schrenk D, Munzel P, Bruck M, Gschaidmaier H, Oesch F and Bock KW: Drug-metabolizing enzyme activities in freshly isolated oval cells and in an established oval cell line from carcinogen-fed rats. Cell Biol Toxicol 10: 59-65, 1994.
39. Lerche C, Le Jossic C, Fautrel A, de Waziers I, Ballet F, Guillouzo A and Corcos L: Rat liver epithelial cells express functional cytochrome P450 2E1. Carcinogenesis 17: 1101-1106, 1996.
40. Cameron RG, Blanck A and Armstrong D: Sex differences in response to four promotion regimens in spite of common first cellular steps in the hepatocellular cancer process initiated by diethylnitrosaminc. Cancer Lett 50: 109-113, 1990.
41. Dunsford HA, Karnasuta C, Hunt JM, Sell S: Different lineages of chemically induced hepatocellular carcinoma in rats defined by monoclonal antibodies. Cancer Res 49: 4894-4900, 1989.
42. Denda A, Laconi E, Rao PM, Rajalakshmi S, Sarma DS: Sequential histopathological analysis of hepatocarcinogenesis in rats during promotion with orotic acid. Cancer Lett 82: 55-64, 1994
43. Rice JM, Diwan BA, Hu H, Ward JM, Nims RW, and Lubet RA: Enhancement of hepatocarcinogenesis and induction of specific cytochrome P450-dependent monooxygenase activities by the barbitu-rates allobarbital, aprobarbital, pentobarbital, secobarbital and 5-phenyl- and 5-ethylbarbituric acids. Carcinogenesis 15: 395-402, 1994.
44. Tsao MS, Smith JD and Grisham JW: The modulation of growth of normal rat liver epithelial cells in calcium-poor medium by epidermal growth factor, phenobarbital, phorbol ester, and retinoic acid. In Vitro Cell Dev Biol 21: 249-253, 1985.
45. Peraino C, Fry RJ and Staffeldt E: Effects of varying the onset and duration of exposure to phenobarbital on its enhancement of 2-acetylaminofluorenc-induced hepatic tumorigenesis. Cancer Res 37: 3623-3627, 1977.
46. Zhang JT and Nicholson BJ: Sequence and tissue distribution of a second protein of hepatic gap junctions. Cx26, as deduced from its cDNA. J Cell Biol 109: 3391-3401, 1989.
47. Neveu M, Hully J, Babcock K, Hertzberg E, Nicholson B, Paul D and Pilot H: Multiple mechanisms are responsible for altered expression of gap junction genes during oncogenesis in rat liver. J Cell Sci 707: 83-95, 1994.
48. Novikoff PM, Ikeda T, Hixson DC and Yam A: Characterization of and interactions between ductule cells and hepatocytes in early stages of rat hepatocarcinogenesis studies by ethionine. Am J Pathol 139: 1352-1368, 1991.
49. de Feijter AW, Matesic DF, Ruch RJ, Guan X, Chang CC and Trosko JE: Localization and function of the connexin 43 gap-junction protein in normal and various oncogene-expressing rat liver epithelial cells. Mol Carcinog 16: 2113-212, 1996.
50. Wu JC, Merlino G and Fausto N: Establishment and characterization of differentiated, nontransformed hepatocytc cell lines derived from mice transgenic for transforming growth factor alpha. Proc Nail Acad Sci USA 91: 674-678, 1994.
51. Zhang M and Thorgeirsson SS: Modulation of connexins during differentiation of oval cells into hepatocytes. Exp Cell Res 213: 37-42, 1994.
52. Elfgang C, Eckcrt R, Lichtenberg-Frate H, Butterweck A, Traub O, Klein RA, Hulser DF and Willecke K: Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol 129: 805-817, 1995.
53. Phipps M, Darozewski J and Phipps J: How the neighborhood coherence principle (NCP) can give rise to tissue homeostasis: a cellular automaton approach. J Theor Biol 185: 475-487, 1997.
54. Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Juneja SC, Kidder GM and Rossant J: Cardiac malformation in neonatal mice lacking connexin43. Science 267: 1831-1834, 1995
55. Martyn KD, Kurata WE, Warn-Cramer BJ, Burt JM, TenBroek E and Lau AF: Immortalized connexin43 knockout cell lines display a subset of biological properties associated with the transformed phenotype. Cell Growth Differ 8: 1015-1027, 1997.
56. Naus CC, Bechberger JF, Zhang Y, Venance L, Yamasaki H, Juneja SC, Kidder GM and Giaume C: Altered gap junctional communication, intercellular signaling, and growth in cultured astrocytes deficient inconnexin43. J Neurosci Res 49 528-540, 1997.
57. Temme A, Buchmann A, Gabriel HD, Nelles E, Schwarz M and Willecke K: High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr Biol 7: 713-716, 1997.
58. Krutovskikh VA, Oyamada M and Yamasaki H: Sequential changes of gap-junctional intercellular communications during multistage rat liver carcinogenesis: direct measurement of communication in vivo. Carcinogenesis 12: 1701-1706, 1991.
59. Sakamoto H, Oyamada M, Enomoto K and Mori M: Differential changes in expression of gap junction proteins connexin 26 and 32 during hepatocarcinogenesis in rats. Jpn J Cancer Res 83: 1210-1215, 1992.
60. Ito S, Tateno C, Tuda M and Yoshitake A: Immunohistochemical demonstration of the gap junctional protein connexin 32 and proliferating cell nuclear antigen in glutathione S-transterase placental form-negative lesions of rat liver induced by diethylnitrosamine and clofibrate. Toxicol Pathol 24: 690-695, 1996.
61. Tsuda H, Asamoto M, Iwahori Y, Hori T, Ota T, Baba-Toriyarna H, Uehara N, Kim DJ, Krutovskikh VA, Takasuka N, Tsuchiya T, Mutai M, Tatematsu M and Yamasaki H: Decreased connexin32 and a characteristic enzyme phenotype in clofibrate-induccd preneoplastic lesions not shared with spontaneously occurring lesions in the rat liver. Carcinogenesis 17: 2441-2448, 1996.
62. Krutovskikh V, Mazzoleni G, Mironov N, Omori Y, Aguelon AM, Mesnil M, Berger F, Partensky C and Yamasaki H: Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int J Cancer 56: 87-94, 1994.
63. Omori Y, Krutovskikh V, Mironov N, Tsuda H and Yamasaki H: Cx32 gene mutation in a chemically induced rat liver tumour. Carcinogenesis 17: 2077-2080, 1996.
64. Saito T, Barbin A, Omori Y and Yamasaki H: Connexin 37 mutations in rat hepatic angiosarcomas induced by vinyl chloride. Cancer Res 57: 375-377, 1997.
65. Sato K, Gratas C, Lampe J, Biernat W, Kleihues P, Yamasaki H and Ohgaki H: Reduced expression of the P2 form of the gap junction protein connexin43 in malignant meningiomas. J Neuropathol Exp Neurol 56: 835-839, 1997.
66. Potter VP: Phenotypic diversity in experimental hepatomas: The concept of partially blocked ontogeny. Br J Cancer 38: 1-23, 1978.
67. Ito N, Moore MA and Bannasch P: Modification of the development of N-nitrosomorpholine-induced hepatic lesions by 2-acetylamino-fluorene, phenobarbital and 4,4'-diaminodiphenylmethane: a sequential histological and histochemical analysis. Carcinogenesis 5: 335-342, 1984.
68. Diwan BA, Ward JM, Kurata Y and Rice JM. Dissimilar frequency of hepatoblastomas and hepatic cystadenomas and adenocarcinomas arising in hepatocellular neoplasms of D2B6F1 mice initiated with N-nitrosodiethylamine and subsequently given Aroclor-1254, dichlorodiphenyltrichloroethane, or phenobarbital. Toxicol Pathol 22: 430-439, 1994.
69. Ren P, Mehta PP and Ruch RJ: Inhibition of gap junctional intercellular communication by tumor promoters in connexin43 and connexin32-expressing liver cells: cell specificity and role of protein kinase C. Carcinogenesis 19: 169-175, 1998.
70. Ruch RJ, Klaunig JE and Pereira MA: Inhibition of intercellular communication between mouse hepatocytes by tumor promoters. Toxicol Appl Pharmacol 87: 111-120, 1987.
71. Kato Y, Kenne K, Haraguchi K, Masuda Y, Kimura R and Warngard L: Inhibition of cell-cell communication by methylsulfonyl metabolites of polychlorinated biphenyl congeners in rat liver epithelial IAR 20 cells. Arch Toxicol 72: 178-182, 1998.
72. Spray DC, Fujita M, Saez JC, Choi H, Watanabe T, Hertzberg E, Rosenberg LC and Reid LM: Proteoglycans and glycosaminoglycans induce gap junction synthesis and function in primary liver cultures. J Cell Biol 705: 541-551, 1987.
73. Traub O, Look J, Paul D and Willecke K: Cyclic adenosine monophosphate stimulates biosynthesis and phosphorylation of the 26 kDa gap junction protein in cultured mouse hepatocytes. Eur J Cell Biol 43: 48-54, 1987.
74. Kojima T, Yamamoto M, Mochizuki C, Mitaka T, Sawada N and Mochizuki Y: Different changes in expression and function of connexin 26 and connexin 32 during DNA synthesis and redifferentiation in primary rat hepatocytes using a DMSO culture system. Hepatology 26: 585-597, 1997.
75. Mesnil M, Piccoli C and Yamasaki H: An improved long-term culture of rat hepatocytes to detect liver tumour-promoting agents: results with phenobarbital. Eur J Pharmacol 248: 59-66, 1993.
76. Rojkind M, Novikoff PM, Greenwel P, Rubin J, Rojas-Valencia L, de Carvalho AC, Stockert R, Spray D, Hertzberg EL and Wolkoff AW: Characterization and functional studies on rat liver fat-storing cell line and freshly isolated hepatocyte coculture system. Am J Pathol 146: 1508-1520, 1995.
77. Bex V, Mercier T, Chaumontet C, Gaillard-Sanchez I, Flechon B, Mazet F, Traub O and Martel P: Retinoic acid enhances connexin43 expression at the post-transcriptional level in rat liver epithelial cells. Cell Biochem Funct 13: 69-77, 1995.
78. Yu W, Dahl G and Werner R: The connexin43 gene is responsive to oestrogen. Proc R Soc Lond B Biol Sci 255: 125-132, 1994.